Devlin Jodi 4
4 · TriSalus Life Sciences, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-27+63,750→ 63,750 totalExercise: $5.30Exp: 2035-01-26→ Common Stock (63,750 underlying) - Award
Common Stock
2025-01-27+10,625→ 28,125 total
Footnotes (2)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.